Kao's OTC Eczema Solution Introduces Ultra-thin Membrane Patch Technology
Kao USA Inc. introduces its new OTC brand, re/cover, a two-step steroid-free treatment for eczema.
Step one, the Calming Eczema Serum, is specially designed to alleviate eczema-related itching. It incorporates ingredients like horse chestnut and allantoin to reduce sensitivity and includes colloidal oatmeal for additional skin soothing.
The second step, the Moisture Patch, utilizes Kao's Fine Fiber technology, incorporating an ultra-thin membrane inspired by electrospinning technology. This patch is applied after the Calming Eczema Serum, creating a transparent, breathable "second skin" hydrating barrier that gradually disappears over time. Importantly, this barrier does not rely on traditional adhesives and effectively safeguards the treatment area while sealing in essential moisture. These patches can be worn for up to eight hours.

breathable second skin hydra
Users follow a seven-day regimen, utilizing the serum along with 14 patches (one for daytime and one for nighttime). This innovative system is set to debut on November 1, 2023, available at recoverskincare.com for $39.99.
Karen Frank, President of Consumer Care Business for the Americas and EMEA, expressed, "The launch of re/cover marks a significant milestone for Kao. We are the pioneers in introducing this groundbreaking system to the U.S. market. It underscores our unswerving dedication to revolutionizing eczema care and maintaining our leadership in therapeutic skin solutions. With re/cover, we are not merely altering the landscape; we are establishing a new benchmark for skincare excellence."
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Starface and Glossier Unveil Nostalgic Hydrocolloid Patch Fusion
-
Lessons from Disco's Demise: Navigating the Complex Terrain of Men's Skincare
-
LipoTrue Unveils Revolutionary Skin Solutions: Col-4-Frag remastered™ and Calisensix™ at in-cosmetics Asia 2023
-
Active Concepts Introduces Game-Changing BioAuthentic Exosomes Skincare Line
-
The Gen Z-focused skin care brand [coat]s Makes Striking US Debut on Amazon and CVS
-
Brenntag Achieves Certification for PCF Data Calculation Method
-
Premium Label & Packaging Solutions (PLPS) Unifies Operations with New Leadership
-
Olaplex Grapples with Persistent Sales Decline in Q3 Despite Marginal Improvement
-
Silab's Myoline: Groundbreaking Anti-Stress Mineral Concentrate Promises 'Botox' Efficacy and Skin Well-Being Boost
-
Assessing Vaselinum Album and Flavum Consistency Using the Hollow Cone Method (EU Pharmacopeia)
Recommend Reading
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
US Tariff Pressure on Canada Raises Risks for North American Chemical Supply Chains
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
Business Society’s Market Outlook for China’s Hydrofluoric Acid on August 21, 2026: A Volatile Pattern
-
This Week, China's Phenol Market Rises and Then Falls
-
Fundamental Dual Support, Lithium Carbonate Price Increase Exceeds Expectations
-
Key Reactions and Uses of Lithium Aluminum Hydride
-
Business Society’s DOP Market Outlook on August 21, 2026: Clearly Upward Trend